10 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 10 of 10 clinical reviews.
A detailed head-to-head comparison of flibanserin (Addyi) and bremelanotide (Vyleesi) across special populations including perimenopausal women, cancer survivors, women with cardiovascular risk, and those considering a switch between therapies.
Compare flibanserin (Addyi) and bremelanotide (Vyleesi) side-effect profiles, clinical trial data, dosing, contraindications, and which drug may suit different patients with HSDD.
A clinical comparison of Addyi (flibanserin) and Vyleesi (bremelanotide) for hypoactive sexual desire disorder, including mechanism, trial data, switching rationale, combination therapy risks, and prescribing guidance.
A detailed comparison of Addyi (flibanserin) and Vyleesi (bremelanotide) covering pricing, insurance coverage, pharmacy access, and clinical value for HSDD treatment.
A clinical comparison of flibanserin (Addyi) and bremelanotide (Vyleesi) for hypoactive sexual desire disorder, including trial data, dosing, side effects, and practical guidance.
A head-to-head clinical comparison of flibanserin (Addyi) and bremelanotide (Vyleesi) for hypoactive sexual desire disorder, covering trial data, durability of effect, switching criteria, and real-world outcomes.
A comparison of Addyi (flibanserin) and Vyleesi (bremelanotide) for hypoactive sexual desire disorder, covering trial data, real-world outcomes, side-effect profiles, and switching guidance.
A clinical comparison of Addyi (flibanserin) and Vyleesi (bremelanotide) for hypoactive sexual desire disorder, including when and how to switch between them safely.
A head-to-head clinical comparison of flibanserin (Addyi) and bremelanotide (Vyleesi) covering titration schedules, tolerability profiles, and guidance on switching, prepared by the HealthRX.com Editorial Team.
Flibanserin (Addyi) and bremelanotide (Vyleesi) treat HSDD through different mechanisms. When one fails, the other may succeed. Learn the clinical criteria for switching, the trial data behind each drug, and the step-by-step protocol HealthRX.com clinicians use.